By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Drugs Made In America Acquisition Corp. Ordinary Shares

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

NASDAQ Currency in USD
$10.25
-$0.03
-0.29%
Last Update: 11 Sept 2025, 20:00
$343.55M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$9.95 - $10.30
52 Week Range

DMAA Stock Price Chart

Explore Drugs Made In America Acquisition Corp. Ordinary Shares interactive price chart. Choose custom timeframes to analyze DMAA price movements and trends.

DMAA Company Profile

Discover essential business fundamentals and corporate details for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) to support your stock research and investment decisions.

Sector

Financial Services

Industry

Shell Companies

IPO Date

Employees

2.00

CEO

Lynn Stockwell

Description

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

DMAA Financial Timeline

Browse a chronological timeline of Drugs Made In America Acquisition Corp. Ordinary Shares corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

DMAA Stock Performance

Access detailed DMAA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run